anx_I__cpt_4__point_17__point_p__text_1
a description of the criteria for discontinuing parts of the clinical trial or the entire clinical trial;
← (p) · All articles · (q) →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.